{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:56:06Z","timestamp":1791820566826,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hefei Municipal Health Commission","award":["hhw-2016yb016"],"award-info":[{"award-number":["hhw-2016yb016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary carnitine deficiency (PCD) is a rare autosomal recessive fatty acid oxidation disorder caused by variants in the <jats:italic>SLC22A5<\/jats:italic> gene, with its prevalence and the spectrum of mutations in <jats:italic>SLC22A5<\/jats:italic> varying across races and regions. This study aimed to analyze the clinical and genetic characteristics of PCD patients, including newborns and their mothers, identified by newborn screening (NBS) in Hefei, China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The dried blood spot samples from newborns were analyzed using tandem mass spectrometry (MS\/MS) from July 2015 to December 2024. Newborns and their mothers with low free carnitine (C0) levels identified during initial screening were subsequently recalled. Next-generation sequencing was employed to analyze gene mutations in patients whose rescreening results indicated that C0 levels remained below the critical reference value.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 897,050 newborns were screened for PCD, and 46 cases were diagnosed, resulting in an incidence rate of 1 in 19,501. Among the screened population, 34 mothers were identified as PCD patients. A total of 26 different variants were detected in the <jats:italic>SLC22A5<\/jats:italic> gene, including four novel variants found in both PCD newborns and their mothers (c.253\u00a0C\u2009&gt;\u2009T, c.976_977delinsAGCAGT, c.384dup, and c.236_271del). Of the 44 PCD newborns tested at our center, seven exhibited homozygous mutations, 35 exhibited compound heterozygous mutations, and two cases showed no detectable gene mutation. The most common mutation was c.1400\u00a0C\u2009&gt;\u2009G (45.88%), followed by c.51\u00a0C\u2009&gt;\u2009G (16.47%) and c.760\u00a0C\u2009&gt;\u2009T (8.24%). Among the 34 PCD mothers, 15 had homozygous mutations and 19 had compound heterozygous mutations; 60.29% of the mutations were c.1400\u00a0C\u2009&gt;\u2009G. The C0 levels in patients with <jats:italic>SLC22A5<\/jats:italic> truncation mutations were significantly lower than those in the non-truncation mutation group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Furthermore, within the truncation mutation group, the C0 levels of patients with the S467C mutation were higher than those of patients without the S467C mutation (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>MS\/MS combined with genetic testing could effectively enhance the diagnostic accuracy of PCD. Our study identified four novel mutations, expanding the variant spectrum of the <jats:italic>SLC22A5<\/jats:italic> gene.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13052-025-01911-1","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:19:53Z","timestamp":1741699193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Newborn screening of primary carnitine deficiency: clinical and molecular genetic characteristics"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8390-406X","authenticated-orcid":false,"given":"Haili","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangsheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1096-7192(02)00169-5","volume":"77","author":"SD Cederbaum","year":"2002","unstructured":"Cederbaum SD, Koo-McCoy S, Tein I, Hsu BY, Ganguly A, Vilain E, et al. Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency. Mol Genet Metab. 2002;77:195\u2013201.","journal-title":"Mol Genet Metab"},{"key":"1911_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jimd.12475","volume":"45","author":"LL Crefcoeur","year":"2022","unstructured":"Crefcoeur LL, Visser G, Ferdinandusse S, Wijburg FA, Langeveld M, Sjouke B. Clinical characteristics of primary carnitine deficiency: A structured review using a case-by-case approach. J Inherit Metab Dis. 2022;45:386\u2013405.","journal-title":"J Inherit Metab Dis"},{"key":"1911_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pcl.2017.11.002","volume":"65","author":"JM Saudubray","year":"2018","unstructured":"Saudubray JM, Garcia-Cazorla A. Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management. Pediatr Clin North Am. 2018;65:179\u2013208.","journal-title":"Pediatr Clin North Am"},{"key":"1911_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jimd.12158","volume":"43","author":"J Rasmussen","year":"2020","unstructured":"Rasmussen J, Duno M, Lund AM, Steuerwald U, Hansen SH, Joensen HD, et al. Increased risk of sudden death in untreated primary carnitine deficiency. J Inherit Metab Dis. 2020;43:290\u20136.","journal-title":"J Inherit Metab Dis"},{"key":"1911_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ymgme.2006.10.003","volume":"90","author":"LA Schimmenti","year":"2007","unstructured":"Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ, et al. Expanded newborn screening identifies maternal primary carnitine deficiency. Mol Genet Metab. 2007;90:441\u20135.","journal-title":"Mol Genet Metab"},{"key":"1911_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1067\/mpd.2001.111813","volume":"138","author":"B Wilcken","year":"2001","unstructured":"Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr. 2001;138:581\u20134.","journal-title":"J Pediatr"},{"key":"1911_CR7","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863:2422\u201335.","journal-title":"Biochim Biophys Acta"},{"key":"1911_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/humu.21607","volume":"33","author":"EC Rose","year":"2012","unstructured":"Rose EC, di San Filippo CA, Ndukwe Erlingsson UC, Ardon O, Pasquali M, Longo N. Genotype-phenotype correlation in primary carnitine deficiency. Hum Mutat. 2012;33:118\u201323.","journal-title":"Hum Mutat"},{"key":"1911_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jimd.12030","volume":"42","author":"C Wilson","year":"2019","unstructured":"Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D. The decision to discontinue screening for carnitine uptake disorder in new Zealand. J Inherit Metab Dis. 2019;42:86\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"1911_CR10","first-page":"577","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, Fang H. Clinical and gene analysis of fatty acid oxidation disorders found in neonatal tandem mass spectrometry screening. Pharmgenomics Pers Med. 2023;16:577\u201387.","journal-title":"Pharmgenomics Pers Med"},{"key":"1911_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cca.2019.03.1622","volume":"494","author":"Y Lin","year":"2019","unstructured":"Lin Y, Zheng Q, Zheng T, Zheng Z, Lin W, Fu Q. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a Southern Chinese population. Clin Chim Acta. 2019;494:106\u201311.","journal-title":"Clin Chim Acta"},{"key":"1911_CR12","doi-asserted-by":"publisher","first-page":"1062715","DOI":"10.3389\/fgene.2022.1062715","volume":"13","author":"S Chang","year":"2022","unstructured":"Chang S, Yang Y, Xu F, Ji W, Zhan X, Gao X, et al. Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China. Front Genet. 2022;13:1062715.","journal-title":"Front Genet"},{"key":"1911_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cca.2020.04.039","volume":"507","author":"Y Lin","year":"2020","unstructured":"Lin Y, Xu H, Zhou D, Hu Z, Zhang C, Hu L, et al. Screening 3.4 million newborns for primary carnitine deficiency in Zhejiang Province, China. Clin Chim Acta. 2020;507:199\u2013204.","journal-title":"Clin Chim Acta"},{"key":"1911_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13023-021-02126-3","volume":"16","author":"Y Lin","year":"2021","unstructured":"Lin Y, Lin B, Chen Y, Zheng Z, Fu Q, Lin W, et al. Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening. Orphanet J Rare Dis. 2021;16:503.","journal-title":"Orphanet J Rare Dis"},{"key":"1911_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymgme.2009.12.015","volume":"100","author":"NC Lee","year":"2010","unstructured":"Lee NC, Tang NL, Chien YH, Chen CA, Lin SJ, Chiu PC, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab. 2010;100:46\u201350.","journal-title":"Mol Genet Metab"},{"key":"1911_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","volume":"12","author":"AW El-Hattab","year":"2010","unstructured":"El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, et al. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med. 2010;12:19\u201324.","journal-title":"Genet Med"},{"key":"1911_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1750-1172-7-68","volume":"7","author":"PL Magoulas","year":"2012","unstructured":"Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2012;7:68.","journal-title":"Orphanet J Rare Dis"},{"key":"1911_CR18","first-page":"5","volume":"16","author":"N Shibata","year":"2018","unstructured":"Shibata N, Hasegawa Y, Yamada K, Kobayashi H, Purevsuren J, Yang Y, et al. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening vs. expanded newborn screening. Mol Genet Metab Rep. 2018;16:5\u201310.","journal-title":"Mol Genet Metab Rep"},{"key":"1911_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fgene.2019.00086","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang L, Wang B, Liu S, Yu B, Wang T. Application of Next-Generation sequencing following tandem mass spectrometry to expand newborn screening for inborn errors of metabolism: A multicenter study. Front Genet. 2019;10:86.","journal-title":"Front Genet"},{"key":"1911_CR20","doi-asserted-by":"publisher","first-page":"E1632","DOI":"10.1002\/humu.21311","volume":"31","author":"FY Li","year":"2010","unstructured":"Li FY, El-Hattab AW, Bawle EV, Boles RG, Schmitt ES, Scaglia F, et al. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat. 2010;31:E1632\u201351.","journal-title":"Hum Mutat"},{"key":"1911_CR21","doi-asserted-by":"publisher","first-page":"e1583","DOI":"10.1002\/mgg3.1583","volume":"9","author":"Y Chen","year":"2021","unstructured":"Chen Y, Lin Q, Zeng Y, Qiu X, Liu G, Zhu W. Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency. Mol Genet Genomic Med. 2021;9:e1583.","journal-title":"Mol Genet Genomic Med"},{"key":"1911_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/humu.9053","volume":"20","author":"NL Tang","year":"2002","unstructured":"Tang NL, Hwu WL, Chan RT, Law LK, Fung LM, Zhang WM. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients. Hum Mutat. 2002;20:232.","journal-title":"Hum Mutat"},{"key":"1911_CR23","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/humu.23315","volume":"38","author":"M Frigeni","year":"2017","unstructured":"Frigeni M, Balakrishnan B, Yin X, Calderon FRO, Mao R, Pasquali M, et al. Functional and molecular studies in primary carnitine deficiency. Hum Mutat. 2017;38:1684\u201399.","journal-title":"Hum Mutat"},{"key":"1911_CR24","first-page":"17","volume":"3","author":"M Kilic","year":"2012","unstructured":"Kilic M, Ozgul RK, Coskun T, Yucel D, Karaca M, Sivri HS, et al. Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency. JIMD Rep. 2012;3:17\u201323.","journal-title":"JIMD Rep"},{"key":"1911_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10545-006-0376-y","volume":"29","author":"S Vijay","year":"2006","unstructured":"Vijay S, Patterson A, Olpin S, Henderson MJ, Clark S, Day C, et al. Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis. 2006;29:627\u201330.","journal-title":"J Inherit Metab Dis"},{"key":"1911_CR26","first-page":"59","volume":"64","author":"M Piccione","year":"2012","unstructured":"Piccione M, Serra G, Sanfilippo C, Andreucci E, Sani I, Corsello G. A new mutation in EDA gene in X-linked hypohidrotic ectodermal dysplasia associated with keratoconus. Minerva Pediatr. 2012;64:59\u201364.","journal-title":"Minerva Pediatr"},{"key":"1911_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13052-020-00922-4","volume":"46","author":"G Serra","year":"2020","unstructured":"Serra G, Corsello G, Antona V, D\u2019Alessandro MM, Cassata N, Cimador M, et al. Autosomal recessive polycystic kidney disease: case report of a newborn with rare PKHD1 mutation, rapid renal enlargement and early fatal outcome. Ital J Pediatr. 2020;46:154.","journal-title":"Ital J Pediatr"},{"key":"1911_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13052-022-01365-9","volume":"48","author":"G Serra","year":"2022","unstructured":"Serra G, Giambrone C, Antona V, Cardella F, Carta M, Cimador M, et al. Congenital hypopituitarism and multiple midline defects in a newborn with non-familial Cat eye syndrome. Ital J Pediatr. 2022;48:170.","journal-title":"Ital J Pediatr"},{"key":"1911_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ajmg.a.35334","volume":"158A","author":"M Piccione","year":"2012","unstructured":"Piccione M, Serra G, Consiglio V, Di Fiore A, Cavani S, Grasso M, et al. 14q13.1-21.1 deletion encompassing the HPE8 locus in an adolescent with intellectual disability and bilateral microphthalmia, but without holoprosencephaly. Am J Med Genet A. 2012;158A:1427\u201333.","journal-title":"Am J Med Genet A"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01911-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:19:59Z","timestamp":1741699199000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01911-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01911-1","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"29 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Anhui Women and Children\u2019s Medical Center approved the study protocol (Protocol Number: 2023-011), and written informed consent was obtained from all participants. We confirm that all methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}